Forms and functions of CD44

Immunology

Volumn 93, Issue 2, 1998, Pages 139-148

  Borland, G ^a   Ross, J A ^b   Guy, K ^c  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c EDINBURGH NAPIER UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; HERMES ANTIGEN;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; CARBOHYDRATE ANALYSIS; CELL INTERACTION; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; IMMUNE SYSTEM; LYMPHOPOIESIS; MEMBRANE POTENTIAL; PRIORITY JOURNAL; REVIEW;

EID: 0031910782     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00431.x     Document Type: Review

References (114)

1. TELEN M.J., ROGERS I. & LETARTE M. (1987) Further characterisation of erythrocyte p80 and the membrane protein defect of In (Lu) Lu (a-b-) erythrocytes. Blood 70, 1475.
2. LUCAS M.G., GREEN A.M. & TELEN M.J. (1989) Characterisation of the serum In (Lu)-related antigen: identification of a serum protein related to erythrocyte p80. Blood 73, 596.
3. STAMENKOVIC I., AMIOT M., PESANDO J.M.P. & SEED B. (1989) A lymphocyte molecule involved in lymph node homing is a member of the cartilage link family. Cell 56, 1057.
4. GOLDSTEIN L.S., ZHOU D.F.H., PICKER L.J. et al. (1989) A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56, 1063.
5. ZHOU D.F.H., DING J.F., PICKER L.J., BARGATZE R.F., BUTCHER E.C. & GOEDDEL D.V. (1989) Molecular cloning and expression of Pgp-1. The mouse homology of the human H-CAM (Hermes) lymphocyte homing receptor. J Immunol 143, 3390.
6. SCREATON G.R., BELL M.V., JACKSON D.G., CORNELIS F.B., GERTH U. & BELL J.I. (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89, 12 160.
7. DOUGHERTY G.J., LANSDORP P.M., COOPER D.L. & HUMPHRIES R.K. (1991) Molecular cloning of CD44R1 and CD44R2, two novel isolbrms of the human CD44 lymphocyte 'homing' receptor expressed by hemopoietic cells. J Exp Med 174, 1.
8. SCREATON G.R., BELL M.V., BELL J.I. & JACKSON D.G. (1993) The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor: comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem 268, 12 235.
9. TOLG C., HOFMANN M., HERRLICH P. & PONTA H. (1993) Splicing choice from ten variant exons establishes CD44 variability. Nucl Acids Res 21, 1225.
10. JACKSON D.G., BUCKLEY J. & BELL J.I. (1992) Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 267, 4732.
11. LESLEY J., HYMAN R. & KINCADE P.W. (1993) CD44 and its interaction with extracellular matrix. Adv Immunol 54, 271.
12. GOODFELLOW P.N., BANTING G., WILES M.V. et al. (1982) The gene. MIC4, which controls expression of the antigen defined by monoclonal antibody F10.44.2, is on human chromosome 11. Eur J Immunol 12, 659.
13. HOFMANN M., RUDY W., ZOLLER M. et al. (1991) CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 51, 5292.
14. SHTIVELMAN E. & BISHOP J.M. (1991) Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol 11, 5446.
15. YU Q. & TOOLE B.P. (1996) A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44. J Biol Chem 271, 20 603.
16. JALKANEN S.T., BARGATZE R.F., HERRON L.R. & BUTCHER E.C. (1986) A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 16, 1195.
17. JALKANEN S.T., BARGATZE R.F., DE LOS TOYOS J. & BUTCHER E.C. ( 1987) Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85 kD glycoprotein antigen differentially inhibit lymphocytes binding to lymph node, mucosal or synovial endothelial cells. J Cell Biol 105, 983.
18. PICKER L.J., NAKACHE M. & BUTCHER E.C. (1989) Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 109, 927.
19. CULTY M., MIYAKE K., KINCADE P.W., SILORSKI E., BUTCHER E.C. & UNDERHILL C. (1990) The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 111, 2765.
20. CAMP R.L., SCHEYNIUS A., JOHANSSON C. & PURE E. (1993) CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med 178, 497.
21. DEGRENDELE H.C., ESTESS P., PICKER L.J. & SIEGELMAN M.H. (1996) CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med 183, 1119.
22. KOOPMAN G., HEIDER K.H., HORST E. et al. (1993) Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177, 897.
23. MACKAY C.R., TERPE H.J., STAUDER R., MARSTON W.L., STARK H. & GUNTHERT U. (1994) Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124, 71.
24. GALLUZZO E., ALBI N., FIORUCCI S. et al. (1995) Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur J Immunol 25, 2932.
25. ARCH R., WIRTH K., HOFMANN M. et al. (1992) Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257, 682.
26. GUNTHERT U., HOFMANN M., RUDY W. et al. (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65, 13.
27. HUET S., GROUX H., CAILLOU B., VALENTIN H., PRIEUR A.M. & BERNARD A. (1989) CD44 contributes to T cell activation. J Immunol 143, 798.
28. SHIMIZU Y., VAN SEVENTER G.A., SIRAGANIAN R., WAHL, L. & SHAW S. (1989) Dual role of the CD44 molecule in T cell adhesion and activation. J Immunol 143, 2457.
29. DENNING S.M., LE P.T., SINGER K.H. & HAYNES B.F. (1990) Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol 144, 7.
30. LESLEY J., HOWES N., PERSCHL A. & HYMAN R. (1994) Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J Exp Med 180, 383.
31. SALLES G., ZAIN M., JIANG W.M., BOUSSIOTIS V.A. & SHIPP M.A. (1993) Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies. Blood 82, 3539.
32. KOOFMAN G., GRIFFIOEN A.W., PONTA H., HERRLICH P., VAN DEN BERG F., MANTENHORST E. & PALS S.T. (1993) CD44 splice variants; expression on lymphocytes and in neoplasia. Res Immunol 144, 750.
33. SPANGRUDE G.J. & SCOLLAY R. (1990) Differentiation of hematopoietic stem cells in irradiated mouse thymic lobes. Kinetics and phenotype of progeny. J Immunol 145, 3661.
34. WU L., ANTICA M., JOHNSON G.R., SCOLLAY R. & SHORTMAN K. (1991) Developmental potential of the earliest precursor cells from the adult mouse thymus. J Exp Med 174, 1617.
35. LESLEY J., TROTTER J. & HYMAN R. (1985) The Pgp-1 antigen is expressed on early fetal thymocytes. Immunogenetics 22, 149.
36. TELEN M.J., PALKER T.J. & HAYNES B.F. (1984) Human erythrocyte antigens. II. The In(Lu) gene regulates expression of an antigen on an 80-kilodalton protein of human erythrocytes. Blood 64, 599.
37. RAO N., UDANI M. & TELEN M.J. (1994) Demonstration by monoclonal antibody immobilisaion of erythrocyte antigens and dot blot that both the In and AnWj blood group antigens reside on CD44. Transfusion 34, 25.
38. TELEN M.J., UDANI M., WASHINGTON M.K., LEVESQUE M.C., LLOYD E. & RAO N. (1996) A blood group-related polymorphism of CD44 abolishes a hyaluronan- binding consensus sequence without preventing hyaluronan binding. J Biol Chem 271, 7147.
39. TELEN M.J. (1995) Erythrocyte blood group antigens: not so simple after all. Blood 85, 299.
40. LAURENT T.C. & FRASER J.R.E. (1992) Hyaluronan. FASEB J 6, 2397.
41. ARUFFO A., STAMENKOVIC I., MELNICK M., UNDERHILL C.B. & SEED B. (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61, 1303.
42. CULTY M., NGUYEN H.A. & UNDERHILL C.B. (1992) The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 116, 1055.
43. MIYAKE K., MEDINA K.L., HAYASHI S., ONO S., HAMAOKA T. & KINCADE P.W. (1990) Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med 171, 477.
44. MIYAKE K., UNDERHILL C.B., LESLEY J. & KINCADE P.W. (1990) Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172, 69.
45. YANG B., YANG B.L., SAVANI R.C. & TURLEY E.A. (1994) Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J 13, 286.
46. PEACH R.J., HOLLENBAUGH D., STAMENKOVIC I. & ARUFFO A. (1993) Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 122, 257.
47. WAYNER E.A. & CARTER W.G (1987) Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique α and distinct β subunits. J Cell Biol 105, 1873.
48. CARTER W.G. & WAYNER E.A. (1988) Characterisation of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem 263, 4193.
49. GALLATIN W.M., WAYNER E.A., HOFFMAN P.A., ST JOHN T., BUTCHER E.C. & CARTER W.G. (1989) Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor. Proc Natl Acad USA 86, 4654.
50. JALKANEN S, & JALKANEN M. (1992) Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116, 817.
51. WEBER G.F., ASHKAR S., GLIMCHER M.J. & CANTOR H. (1996) Receptor ligand interaction between CD44 and osteopontin (Eta-1). Science 271, 509.
52. TOYAMASORIMACHI N. & MIYASAKA M. (1994) A novel ligand for CD44 is sulfated proteoglycan. Int Immunol 6, 655.
53. ROTHMAN B.E., BLUE M.L., KELLEY K.A., WUNDERLICH D., MIERZ D.V. & AUNE T.M. (1991) Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44. J Immunol 147, 2493.
54. SETH A., GOTE L., NAGARKATTI M. & NAGARKATTI P.S. (1991) T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90 (MEL-14). Proc Natl Acad Sci USA 88, 7877.
55. PIERRES A., LIPCEY C., MAWAS C. & OLIVE D. (1992) A unique CD44 monoclonal antibody identifies a new T cell activation pathway. Eur J Immunol 22, 413.
56. CULTY M., SHIZARI M., THOMPSON E.W. & UNDERHILL C.B. (1994) Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J Cell Physiol 160, 275.
57. UNDERHILL C.B., NGUYEN H.A., SHIZARI M. & CULTY M. (1993) CD44 positive macrophages take up hyaluronan during lung development. Devel Biol 155, 324.
58. TOOLE B.P. (1991) Proteoglycans and hyaluronan in morphogenesis and differentiation. In: Cell Biology of ECM (ed. E. D. Hay), p. 305. Plenum Press, New York.
59. WHEATLEY S.C., ISACKE C.M. & CROSSLEY P.H. (1993) Restricted expression of the hyaluronan receptor, CD44. during post-implantation mouse embryogenesis suggests key roles in tissue formation and patterning. Development 119, 295.
60. JALKANEN S.T., JALKANEN M., BARGATZE R., TAMMI M. & BUTCHER E.C. (1988) Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J Immunol 141, 1615.
61. KUGELMAN L.C., GANGULY S., HAGGERTY J.G., WEISSMAN S.M. & MILSTONE E.M. (1992) The core protein of epican, a heparan sulfate proteoglycan on keratinocytes, is an alternative form of CD44. J Invest Dermatol 99, 381.
62. TANAKA T., ADAMS D.H., HUBSCHER S., HIRANO H., SIEBENLIST U. & SHAW S. (1993) T-cell adhesion induced by proteoglycanimmobilized cytokine MIP-1β. Nature 361, 79.
63. KJELLEN L. & LINDAHL U. (1991) Proteoglycans: Structures and interactions. Annu Rev Biochem 60, 443.
64. MERTENS G., CASSIMAN J.J., VAN DEN BERGHE H., VERMYLEN J. & DAVID G. (1992) Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. J Biol Chem 267, 20 435.
65. JACKSON D.G., BELL J.I., DICKINSON R., TIMANS J., SHIELDS J. & WHITTLE N. (1995) Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128, 673.
66. BENNETT K.L., JACKSON D.G., SIMON J.C. et al. (1995) CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 128, 687.
67. YANAGASHITA M. & HASCALL V.C. (1992) Cell surface heparan sulfate proteoglycans. J Biol Chem 267, 9451.
68. MCKEE C.M., PENNO M.B., COWMAN M. et al. (1996) Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages: the role of HA size and CD44. J Clin Invest 98, 2403.
69. MCKEE C.M., LOWENSTEIN C.J., HORTON M.R. et al. (1997) Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor κB-dependent mechanism. J Biol Chem 272, 8013.
70. LESLEY J., HE Q., MIYAKE K., HAMANN A., HYMAN R. & KINCADE P.W. (1992) Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J Exp Med 175, 257.
71. MURAKAMI S., MIYAKE K., ABE R., KINCADE P.W. & HODES R.J. (1991) Characterization of autoantibody-secreting B cells in mice undergoing stimulatory (chronic) graft-vs.-host reactions. Identification of a CD44 (hi) population that binds specifically to hyaluronate. J Immunol 146, 1422.
72. MIYAKE K. & KINCADE P.W. (1990) A new cell adhesion mechanism involving hyaluronate and CD44. Curr Top Microbiol Immunol 166, 87.
73. MURAKAMI S., MIYAKE K., JUNE C.H., KINCADE P.W. & HODES R.J. (1990) IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliterative and Ig secretory activity and binds to hyaluronate. J Immunol 145, 3618.
74. LESLEY J. & HYMAN R. (1992) CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Ear J Immunol 22, 2719.
75. HYMAN R., LESLEY J. & SCHULTE R. (1991) Somatic cell mutants distinguish CD44 expression and hyaluronic acid binding. Immunogenetics 33, 392.
76. LIAO H.X., LEVESQUE M.C., PATTON K. et al. (1993) Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J Immunol 151, 6490.
77. EAST J.A., MITCHELL S.D. & HART I.R. (1993) Expression and function of the CD44 glycoprotein in melanoma cell lines. Melanoma Res 3, 341.
78. UFF C.R., NEAME S.J. & ISACKA C.M. (1995) Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism. Eur J Immunol 25, 1883.
79. LESLEY J.L., KINCADE P.W. & HYMAN R. (1993) Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur J Immunol 23, 1902.
80. LIAO H.X., LEE D.M., LEVESQUE M.C. & HAYNES B.F. (1995) N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding. J Immunol 155, 3938.
81. PERSCHL A., LESLEY J., ENGLISH N., TROWBRIDGE I. & HYMAN R. (1995) Role of CD44 cytoplasmic domain in hyaluronan binding. Eur J Immunol 25, 495.
82. NEAME S.J. & ISACKE C.M. (1992) Phosphorylation of CD44 in vivo requires both Ser323 and Ser325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells. EMBO J 11, 4733.
83. PURE E., CAMP R.L., PERITT D., PANETTIERI R.A.J., LAZAAR A.L. & NAYAK S. (1995) Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J Exp Med 181, 55.
84. NEAME S.J., UFF C.R., SHEIKH H., WHEATLEY S.C. & ISACKE C.M. (1995) CD44 exhibits a cell type dependent interaction with Triton X-100 insoluble, lipid rich, plasma membrane domains. J Cell Sci 108, 3127.
85. STAMENKOVIC I., ARUFFO A., AMIOT M. & SEED B. (1991) The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10, 341.
86. HE Q., LESLEY J., HYMAN R., ISHIHARA K. & KINCADE P.W. (1992) Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J Cell Biol 119, 1711.
87. DOUGHERTY G.J., COOPER D.L., MEMORY J.F. & CHIU R.K. (1994) Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1. J Biol Chem 269, 9074.
88. VAN DER VOORT R., MANTENHORST E., SMIT L., OSTERMANN E., VAN DEN BERG F. & PALS S.T. (1995) Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type. Biochem Biophys Res Commun 214, 137.
89. KATOH S., ZHENG Z., ORITANI K., SHIMOZATO T. & KINCADE P.W. (1995) Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 182, 419.
90. LESLEY J., ENGLISH N., PERSCHL A., GREGOROFF J. & HYMAN R. (1995) Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med 182, 431.
91. BENNETT K.L., MODRELL B., GREENFIELD B. et al. (1995) Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol 131, 1623.
92. BARTOLAZZI A., NOCKS A., ARUFFO A., SPRING F. & STAMENKOVIC I. (1996) Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol 132, 1199.
93. TAKAHASHI K., STAMENKOVIC I., CUTLER M., DASGUPTA A. & TANABE K.K. (1996) Keratan sulfate modification of CD44 modulates adhesion to hyaluronate. J Biol Chem 271, 9490.
94. RUDY W., HOFMANN M., SCHWARTZALBIEZ R. et al. (1993) The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 53, 1262.
95. HEIDER K.H., MULDER J.W.R., OSTERMANN E. et al. (1995) Splice variants of the cell surface glycoprotein CD44 associated with metastatic tumour cells are expressed in normal tissues of humans and cynomolgus monkeys. Eur J Cancer 31, 2385.
96. KENNEL S.J., LANKFORD T.K., FOOTE L.J., SHINPOCK S.G. & STRINGER C. (1993) CD44 expression on murine tissues. J Cell Sci 104, 373.
97. FOX S.B., FAWCETT J., JACKSON D.G. et al. (1994) Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 54, 4539.
98. HALE L.P., PATEL D.D., CLARK R.E. & HAYNES B.F. (1995) Distribution of CD44 variant isoforms in human skin: differential expression in components of benign and malignant epithelia. J Cutan Pathol 22, 536.
99. ABBASI A.M., CHESTER K.A., TALBOT I.C. et al. (1993) CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells. Eur J Cancer 29, 1995.
100. IIDA N. & BOURGUIGNON L.Y.W. (1995) New CD44 splice variants associated with human breast cancers. J Cell Physiol 162, 127.
101. WIELENGA V.J.M., HEIDER K.H., OFFERHAUS G.J.A. et al. (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53, 4154.
102. KUPPNER M.C., VAN MEIR E., GAUTHIER T., HAMOU M.F. & DE TRIBOLET N. (1992) Differential expression of the CD44 molecule in human brain tumours. Int J Cancer 50, 572.
103. FAVROT M.C., COMBARET V. & LASSET C. (1993) CD44 - A new prognostic marker for neuroblastoma. N Engl J Med 329, 1965.
104. MATSUMURA Y., HANBURY D., SMITH J. & TARIN D. (1994) Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. Br Med J 308, 619.
105. b antigens with survival in patients with carcinoma of the lung. N Engl J Med 327, 14.
106. NAITOH M., NAKAJIMI T., NAGAMACHI Y. & YAZAWA S. (1994) A clinicopathological evaluation of anti-fucosylated antigens antibody (YB-2) in colorectal carcinoma. Glycosylation Dis 1, 31.
107. LABARRIERE N., PIAU J.P., OTRY C, et al. (1994) H blood group antigen carried by CD44v modulates tumorigenicity of rat colon carcinoma cells. Cancer Res 54, 6275.
108. TANABE K.K., ELLIS L.M. & SAYA H. (1993) Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 341, 725.
109. MULDER J.W.R., KRUYT P.M., SEWNATH M. et al. (1994) Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 344, 1470.
110. YAMAGUCHI A., URANO T., GOI T. et al. (1996) Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. J Clin Oncol 14, 1122.
111. ICHIKAWA W. (1994) Positive relationship between expression of CD44 and hepatic metastases in colorectal cancer. Pathobiol 62, 172.
112. TAKEUCHI K., YAMAGUCHI A., URANO T., GOI T., NAKAGAWARA G. & SHIKU H. (1995) Expression of CD44 variant exons 8 10 in colorectal cancer and its relationship to metastasis. Jpn J Cancer Res 86, 292.
113. IMAZEKI F., YOKOSUKA O., YAMAGUCHI T., OHTO M., ISONO K. & OMATA M. (1996) Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans. Gastroenterol 110, 362.
114. GOTLEY D.C., FAWCETT J., WALSH M.D., REEDER J.A., SIMMONS D.L. & ANTALIS T.M. (1996) Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br J Cancer 74, 342.